Device deal making is back in a big way, despite the munificence of venture funds.
If the first quarter was quiet for takeovers the second saw M&A grind to a halt. What can the matter be?
But this week three transactions did squeak through.
But more traditional device makers seem uninterested in this means of stock market listing.
It takes more than a pandemic to stop medical device companies merging.